American Portfolios Advisors Adaptive Biotechnologies Corp Transaction History

American Portfolios Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Mar 22, 2023	BUY	$32.22 - $44.59 $1,772 - $2,452	55 New	55 $2.25 Million
Q1 2021 Mar 22, 2023	BUY	$37.26 - $67.74 $3,912 - $7,112	105 New	105 $4.23 Million
Q4 2020 Mar 22, 2023	BUY	$45.01 - $65.47 $2,250 - $3,273	50 New	50 $2.96 Million
Q3 2020 Mar 22, 2023	BUY	$35.79 - $48.81 $1,789 - $2,440	50 New	50 $2.43 Million

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.